AlgometRx Awarded Two Small Business Innovation Research Grants from the NIH
In September of 2022, AlgometRx was awarded two Phase 1 SBIR awards from the National Cancer Institute (NCI) and the National Institute...
top of page
BRINGING OBJECTIVITY AND PRECISION TO PAIN MANAGEMENT
About
ABOUT ALGOMETRX
OUR TECHNOLOGY
The AlgometRx Nociometer® enables a fundamental paradigm shift in pain assessment and analgesic prescribing. Our novel technology and algorithms analyze pupil dilation in response to neuroselective stimulation to formulate a nociceptive profile. This new construct is used to characterize pain type, intensity and assess the pharmacodynamic impact of analgesics. This transformative platform technology can be applied to any population.
The Team
OUR TEAM
Julia Finkel, MD
Founder & Chief Scientific Advisor
Kevin Jackson
Product Engineer
David Gross, MSEE
Chariman, Board of Directors
David Heller, MBA
Board of Directors
OUR ADVISORS
Susan Alpert, PhD, MD
Regulatory Expert
Misha Backonja, MD
Neurologist and Clinical Trial Expert
Irving McConnell, DVM
Veterinarian
Marilyn Huestis, PhD
Pharmacologist/
Toxicologist
OUR COLLABORATORS
News and Updates
Contact
STAY IN TOUCH
bottom of page